Volume 1 of THE REPORT ON THE INVESTIGATION INTO ARIA ATLANTIC AFFAIRS

 This report marks the increase in spending budget for the upcoming 2022 satellite acquisition and its partnering companies including MAREK & MOIRENE

A increase in the minimum investments amount in ARIAENX and other trading and investment funds owned by Aria Atlantic, LLC and all private funds owned by Radhesh Aria by April of 2022. Tollinger, Strovelyn & Sokilov and other companies to receive increased attention of Aria Atlantic, LLC financial departments. 

KIRPHA PHARMACEUTICALS

The report impacts the financial departments of Kirpha Pharmaceuticals and along with its all of its current assets. The report marks the increase in funding rounds by 10% by the end of February and to 30% by March. This increase in funding will directly be associated with all current Kirpha Experimentation Facilities and its employees, for more information on Kirpha Experimentation Facilities refer to report K9-36F

KX09 PRODUCTIONS AND PICTURES

As all current assets and stakes of KX09 are held completely private, The report will increase all current monthly expenditure by 49% and is expected to begin the production of Life of the Aria's much more efficiently and cost effective by May of 2022

 --------------------TO BE CONTINUED-------------------------------

 

 

Post a Comment